Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Trading Down 0.8% – Here’s Why

Fidelity Disruptive Medicine ETF (NASDAQ:FMED)’s stock price fell 0.8% during trading on Thursday . The company traded as low as $25.67 and last traded at $25.73. 6,654 shares were traded during trading, a decline of 3% from the average session volume of 6,858 shares. The stock had previously closed at $25.93.

Fidelity Disruptive Medicine ETF Trading Down 0.8%

The business’s fifty day moving average price is $25.17 and its 200 day moving average price is $26.37. The company has a market capitalization of $59.18 million, a P/E ratio of 41.33 and a beta of 0.99.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

Hedge funds and other institutional investors have recently made changes to their positions in the business. Jane Street Group LLC lifted its holdings in Fidelity Disruptive Medicine ETF by 0.8% during the 1st quarter. Jane Street Group LLC now owns 66,382 shares of the company’s stock valued at $1,567,000 after purchasing an additional 499 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in Fidelity Disruptive Medicine ETF by 4.6% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 714,991 shares of the company’s stock valued at $19,712,000 after purchasing an additional 31,629 shares during the last quarter. BXM Wealth LLC bought a new position in Fidelity Disruptive Medicine ETF during the 4th quarter valued at about $243,000. Glass Jacobson Investment Advisors llc lifted its holdings in Fidelity Disruptive Medicine ETF by 44.0% during the 4th quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock valued at $34,000 after purchasing an additional 385 shares during the last quarter. Finally, Vise Technologies Inc. bought a new position in Fidelity Disruptive Medicine ETF during the 4th quarter valued at about $234,000.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.